Karin Lykke-Hartmann - Distinguished Senior Innovator at Aarhus University

Karin Lykke-Hartmann, Professor at the Department of Biomedicine, aims to revolutionise fertility treatment through the QUEINI project by developing methods to improve the egg fertilisation and increase the chances of pregnancy.

The initiative involves early-career researchers and is expected to lead to the establishment of a new biotechnology company.

Karin is also founder and CEO of Notify Therapeutics.

PORTRAIT

"We have identified a crucial detail in fertility treatment"

For years, Professor Karin Lykke Hartmann has researched women’s fertility.

Now her research points to a new form of treatment that reduces stress in a woman’s eggs and increases the chances of pregnancy.

Pure profile

Learn more about Karin Lykke-Hartmann's research, publications and academic activities on her Pure profile.

View Pure profile

Department of Biomedicine

Karin Lykke-Hartmann is a Professor at the Department of Biomedicine.

Learn more about the department here

DSI projects

The innovation project(s) that formed the basis for the appointment to the Distinguished Senior Innovator programme.

QUEINI

The QUEINI project is developing IVF solutions to improve fertilisation of the egg, using mouse as the experimental model. Behind the QUEINI project are a team of reproductive scientists with strong and documented experience in the fertility space. Their work has uncovered how to improve egg quality for better fertility readouts.

Revised 10.07.2026

Nina Heiberg Lyhne